LDS/Medical Tests/17-Hydroxypregnenolone, Serum

17-Hydroxypregnenolone, Serum

17-hydroxypregnenolone is an intermediate product during the biosynthesis of steroid hormone in the adrenal gland and gonads. During the biosynthesis of steroid hormones, 17-α-hydroxylase converts pregnenolone to 17-hydroxypregnenolone and progesterone to 17-α-hydroxyprogesterone (17-OHP) in the zona glomerulosa and the zona reticularis. 17-hydroxypregnenolone is then activated by 3-β-hydroxysteroid dehydrogenase to form 17- hydroxyprogesterone. Therefore, the measurement of 17-hydroxypregnenolone provides valuable information in the diagnosis of various defects in enzymes involved in steroidogenesis, which is commonly referred as congenital adrenal hyperplasia (CAH).

17-α-hydroxylase deficiency (CYP17) is a rare cause of CAH resulting in an obstruction of cortisol biosynthesis. However, the accumulated intermediates are diverted to increase the synthesis of 11-Deoxycorticosterone (DOC), resulting in clinical symptoms of hypermineralocorticoidism including hypertension in later childhood. ACTH concentration increases in response to decrease in cortisol, which further elicits the mineralocorticoid overproduction. CYP17 mutations also influence sex steroid production in males in utero and in female at the time of puberty as this enzyme is also responsible for converting 17-hydroxypregnenolone to dehydroepiandrosterone (DHEA) and 17-OHP to androstenedione. On the other hand, deficiency of 3-β-hydroxysteroid dehydrogenase, another rare form of CAH, is the blockage in the conversion of pregnenolone to progesterone, 17-hydroxypregnenolone to 17-OHP, and DHEA to androstenedione. Therefore, male fetuses are under-virilized due to the defect in testosterone production, and female fetuses are over-virilized due to the accumulation of DHEA.

In CAH, due to 17-α-hydroxylase deficiency, androstenedione, 17-hydroxypregnenolone, 17-OHP, DHEA, androgen (testosterone, estrone, estradiol), and cortisol are low, while production of mineralocorticoid and its precursors including pregnenolone, 11-DOC, corticosterone, and 18-hydroxycorticosterone are increased. However, CAH due to 3-β-hydroxysteroid dehydrogenase deficiency is characterized by elevated ratio of 17-hydroxypregnenolone to 17-OHP, pregnenolone to progesterone, and DHEA to androstenedione.

  • Differential diagnosis of congenital adrenal hyperplasia when used in conjunction with other intermediates of steroidogenesis, including 11-DOC, DHEA, 17-OHP, androstenedione and cortisol
  • As an aid in diagnosis of 17-α-hydroxylase deficiency or 3-β-hydroxysteroid dehydrogenase deficiency
  • As an aid in diagnosis of hirsutism or infertility in females

Increased in: Congenital adrenal hyperplasia due to 3-β-hydroxysteroid dehydrogenase deficiency

Decreased in: Congenital adrenal hyperplasia due to 17-α-hydroxylase deficiency

Adults

Group Reference Range (ng/dL)
Males 55 – 455
Females 31 – 455

Children - Males:

Age Reference Range (ng/dL)
Premature (26–28 weeks) 1219 – 9799
Premature (29–36 weeks) 346 – 8911
Full term (1–5 months) 229 – 3104
6–12 months 221 – 1981
1–2 years 35 – 712
2–4 years < 249
5–6 years < 319
7–9 years < 188
10–12 years < 393
13–15 years 35 – 465
16–17 years 32 – 478

Children - Females

Age Reference Range (ng/dL)
Premature (26–28 weeks) 1219 – 9799
Premature (29–36 weeks) 346 – 8911
Full term (1–5 months) 229 – 3104
6–12 months 221 – 1981
1–2 years 35 – 712
2–4 years < 280
5–6 years < 350
7–9 years < 213
10–12 years < 399
13–15 years < 408
16–17 years < 424

Tanner Stages - Males

Tanner Stage Reference Range (ng/dL)
Stage I < 209
Stage II < 356
Stage III < 451
Stage IV–V 35 – 478

Tanner Stages - Females

Tanner Stage Reference Range (ng/dL)
Stage I < 236
Stage II < 368
Stage III < 431
Stage IV–V < 413
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS), Immunoassay.

Serum (SST).

Stability

  • Refrigerated: 7 days
  • Frozen- 28 days
Pregnenolone, 17-hydroxyprogesterone, dehydroepiandrosterone (DHEA), androstenedione, ACTH, Cortisol, progesterone, testosterone, estrone, estradiol, 11-DOC, corticosterone, and 18-hydroxycorticosterone.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Horm Res. 2000;53:68-71. [PMID:10971091]
  • Ann Clin Lab Sci. 2001;31:199-204. [PMID:11337910]
  • Clin Chem. 2006;52:1559-67. [PMID:16777916]
  • Stewart PM, Krone NP. “The Adrenal Cortex.” Williams Textbook of Endocrinology, 12th ed. Saunders Company: Philadelphia, PA; 2011. Page 479-544
  • Demers LM. “The Adrenal Cortex.” Textbook of Clinical Chemistry and Molecular Diagnostics, 4th ed. 2006. Page 2003-52.